AIM ImmunoTech Posts Virtual Investor Key Opinion Leader Segment Spotlighting Ampligen Breakthrough Data in Pancreatic Cancer

Go back to AIM ImmunoTech Posts Virtual Investor Key Opinion Leader Segment Spotlighting Ampligen Breakthrough Data in Pancreatic Cancer
Aerosonic Corp. (NYSE: AIM) Delayed: 0.38 --0 (-0%)
Previous Close $0.38    52 Week High $8.92 
Open $0.38    52 Week Low $2.64 
Day High $0.39    P/E 0.61 
Day Low $0.36    EPS $0.62 
Volume 1,383,100